Work

SAGE-718: A First-in-ClassN-Methyl- d -Aspartate Receptor Positive Allosteric Modulator for the Potential Treatment of Cognitive Impairment

Year: 2022

Type: article

Source: Journal of Medicinal Chemistry

DOI: 10.1021/acs.jmedchem.2c00313

Authors: Matthew D. Hill, Maria-Jesus Blanco, Francesco G. Salituro, Zhu Bai, Jacob T. Beckley, Michael A. Ackley, Jing Dai, James J. Doherty, Boyd L. Harrison, Ethan C. Hoffmann, Tatiana M. Kazdoba, David Lanzetta, Michael Lewis, Michael C. Quirk, Albert J. Robichaud

Institution: Sage Therapeutics (United States)

Language: English

Topic: Neuroscience and Neuropharmacology Research

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4283786331

FWCI: 3.979

Cites: 24

Cited by: 43

Related to: 10